Literature DB >> 3552306

Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy.

M Tanaka, H Fujiwara, T Onodera, D J Wu, M Matsuda, Y Hamashima, C Kawai.   

Abstract

To clarify the pathophysiologic role of intramyocardial small artery (IMSA) diseases in hypertrophied hearts, narrowings of the IMSA were quantitatively evaluated in 39 autopsied hearts, 10 from patients with typical hypertrophic cardiomyopathy (HCM), four from patients with HCM showing features mimicking dilated cardiomyopathy (DCM-like HCM), 10 from patients with hypertension, and 15 from normal adults. The relations of narrowings of the IMSA to myocytic hypertrophy, myocardial fiber disarray, and fibrosis were also examined. The external caliber and the ratio of the luminal area to the total vascular area (percent luminal area, % lumen) were calculated by an image analyzer in 85 to 203 IMSAs from each patient. The external calibers of the IMSAs were similar among groups of hearts with HCM, hypertensive hearts, and normal hearts but were greater in those with DCM-like HCM. The mean % lumen of the IMSAs was similarly reduced in the hearts with HCM (29 +/- 5% in the ventricular septum and 31 +/- 5% in the left ventricular free wall) and in hypertensive hearts (30 +/- 8% and 31 +/- 7%) compared with that in normal hearts (40 +/- 5% and 38 +/- 5%) and was the lowest in the ventricular septum of hearts with DCM-like HCM (17 +/- 3%). The mean % lumen of the IMSA was inversely correlated with heart weight (r = -.59), the mean size of myocytes (r = -.66 in the ventricular septum, r = -.63 in the free wall), and percent fibrotic area in the septum (r = -.68). The mean % lumen values of the IMSAs in the tissues with and without disarray in the hearts with HCM were similar. Thus IMSA disease is of pathophysiologic importance in patients with HCM, DCM-like HCM in particular, or with hypertension.

Entities:  

Mesh:

Year:  1987        PMID: 3552306     DOI: 10.1161/01.cir.75.6.1130

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

2.  Tl-201 washout rate in remote normal regions in patients with prior myocardial infarction and left ventricular remodeling.

Authors:  Toshihiko Goto; Nobuyuki Ohte; Hiromichi Miyabe; Seiji Mukai; Seiichiro Sakata; Junichiro Hayano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

3.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

4.  Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling.

Authors:  Nobuyuki Ohte; Hitomi Narita; Akihiko Iida; Kazuaki Wakami; Kaoru Asada; Hidekatsu Fukuta; Takafumi Kato; Junichiro Hyano; Genjiro Kimura
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

5.  Left ventricular remodeling after myocardial infarction impairs early diastolic, but not systolic, function in the radial direction in the remote normal region.

Authors:  Hiroko Kobayakawa; Nobuyuki Ohte; Kazuaki Wakami; Hidekatsu Fukuta; Toshihiko Goto; Tomomitsu Tani; Hitomi Narita; Genjiro Kimura
Journal:  J Echocardiogr       Date:  2010-07-31

Review 6.  Coronary microcirculation in health and disease. Summary of an NHLBI workshop.

Authors:  W M Chilian
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

7.  Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms.

Authors:  Paco E Bravo; Abdel Tahari; Iraklis Pozios; Hong-Chang Luo; Frank M Bengel; Richard L Wahl; M Roselle Abraham; Theodore P Abraham
Journal:  J Nucl Cardiol       Date:  2015-05-20       Impact factor: 5.952

8.  Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Authors:  Paco E Bravo; Hong-Chang Luo; Iraklis Pozios; Stefan L Zimmerman; Celia Pamela Corona-Villalobos; Lars Sorensen; Ihab R Kamel; David A Bluemke; Richard L Wahl; M Roselle Abraham; Theodore P Abraham
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-06-14       Impact factor: 6.875

9.  Limited maximal vasodilator capacity of forearm resistance vessels in patients with hypertrophic cardiomyopathy.

Authors:  T Imaizumi; A Takeshita; K Yamamoto; M Nakamura; K Sueishi
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

10.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  James M Wilson; Rollo P Villareal; Ramesh Hariharan; Ali Massumi; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.